Cart
sales@molnova.com
Home - Products - Others - GRK (GPCRK) - Takeda103A

Takeda103A

CAS No. 865609-72-9

Takeda103A( Takeda-103-A | Takeda 103 A | Takeda-103A | CMPD103A | CMPD-103A )

Catalog No. M24868 CAS No. 865609-72-9

Takeda103A is the GRK2-dependent bovine tubulin oxidation effective inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 267 In Stock
10MG 406 In Stock
25MG 669 In Stock
50MG 945 In Stock
100MG 1251 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Takeda103A
  • Note
    Research use only, not for human use.
  • Brief Description
    Takeda103A is the GRK2-dependent bovine tubulin oxidation effective inhibitor.
  • Description
    Takeda103A is the GRK2-dependent bovine tubulin oxidation effective inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Takeda-103-A | Takeda 103 A | Takeda-103A | CMPD103A | CMPD-103A
  • Pathway
    Others
  • Target
    GRK (GPCRK)
  • Recptor
    GRK2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    865609-72-9
  • Formula Weight
    463.49
  • Molecular Formula
    C24H23F2N7O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CCCN1C(=NN=C1C2=NC=NC=C2)CNC3=CC=CC(=C3)C(=O)NCC4=C(C=CC=C4F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Waldschmidt HV, Homan KT, Cruz-Rodríguez O, et al. Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors. J Med Chem. 2016 Apr 28;59(8):3793-807. doi: 10.1021/acs.jmedchem.5b02000. Epub 2016 Apr 13. PubMed PMID: 27050625.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • GRK6-IN-2

    GRK6-IN-2 is a potent G protein-coupled receptor kinase 6 (GRK6) inhibitor with potential antitumor activity.GRK6-IN-2 has been studied in multiple myeloma.

  • GRK2i

    GRK2 inhibitory polypeptide that specifically inhibits Gβγ activation of GRK2. Corresponds to the Gβγ-binding domain and acts as a cellular Gβγ antagonist.

  • PEN (rat)

    Endogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide.

Sign In Join Free